Effects of Memantine on Pain in Patients with Complex Regional Pain Syndrome--a Retrospective Study.
نویسندگان
چکیده
INTRODUCTION Memantine was discovered in 1968 and is used as a treatment for Alzheimer's disease. We evaluated the use of memantine to treat complex regional pain syndrome in this retrospective study. PATIENTS AND METHODS 56 patients with CRPS, who were treated with trial of memantine for at least two months with 40mg QHS from 2007 until 2009. RESULTS 34 females and 22 male patients. Age-46.0 +/- 9.7 years. Number of years with CRPS-9.24 ± 5.7 years. Mean age-46.0 +/- 9.7 years. Memantine was started at 5 or 10 mg QHS, before being increased by 5 or 10mg every 4-7 days, as tolerated, to a maximumdose of 40 mg - 60 mg, as tolerated. In all, 13 patients showed complete remission from CRPS with VAS 0 and the disappearance of allodynea for at least nine months after the use of memantine. In addition, 18 patients showed partial improvement of VAS and allodynea. Eight patients showed no improvement even after continuous use of memantine at a dose of 40 mg QHS for two months. Seven patients could not take more than 5 mg of memantine per day and had to stop it due to side effects. In terms of subjective improvement in short-term memory, nine patients showed much improvement, 14 patients showed some improvement, three patients showed no changes and one patient did not answer the questionnaire. Regarding subjective feelings of a having better quality of life, 17 patient answered yes, three did not feel any changes, six could not give an answer and two did not fill out the questionnaire. CONCLUSIONS Memantine is a promising option for the treatment of CRPS. A randomised controlled study is needed to evaluate its efficacy.
منابع مشابه
Memantine treatment of complex regional pain syndrome: a preliminary report of six cases.
OBJECTIVES Recent studies have confirmed the contribution of the central nervous system (CNS) to the pathogenesis of Complex Regional Pain Syndrome (CRPS), because animal models of neuropathic pain syndromes demonstrate an overexpression of N-methyl-D-aspartate-receptors in the CNS. The aim of this work was to study the influence of a central acting drug-the N-methyl-D-aspartate receptor antago...
متن کاملتأثیر تجویز ممانتین خوراکی قبل از عمل بر درد پس از اعمال ارتوپدی
Aim and Background: Memantine is one of NMDA receptor antagonists with a rapid onset and limited side effects its inhibitory effects on neuropathic pain has mentioned while using before nerve injury. Few studies were done on evaluating oral memantine effects on acute post-orthopedic surgery pain. Methods and Materials: In a double blind clinical trial, 60 patients with ASAI, II and upper limb ...
متن کاملNMDA receptor antagonists for the treatment of neuropathic pain.
OBJECTIVE The N-methyl-D-Aspartate (NMDA) receptor has been proposed as a primary target for the treatment of neuropathic pain. The aim of the present study was to perform a meta-analysis evaluating the effects of (individual) NMDA receptor antagonists on neuropathic pain, and the response (sensitivity) of individual neuropathic pain disorders to NMDA receptor antagonist therapy. DESIGN PubMe...
متن کاملThe Effects of Ultrasound-Guided Dry Needling on Patients With Myofascial Pain Syndrome: A Review Study
Objectives: Dry Needling (DN) is a novel and effective intervention for patients with Myofascial Pain Syndrome (MPS). Some characteristics, such as needle penetration depth, needle insertion into the target muscle, and trigger points must be identified in this intervention. The Ultrasound (US)-guided DN is a technique that involves needle insertion at the site of injury and the simulation of ti...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Middle East journal of anaesthesiology
دوره 23 1 شماره
صفحات -
تاریخ انتشار 2015